Sanofi, Verily Life Launch JV To Develop Diabetes Management Platform

(RTTNews) - Sanofi (SNYNF, SNY) and Verily Life Sciences, an Alphabet company, announced launch of Onduo, a joint venture created through Sanofi and Verily's diabetes-focused collaboration. Initially, Onduo will focus on the type 2 diabetes community. Onduo is discussing with patient advocacy groups like Taking Control of Your Diabetes to provide input on future product designs.

Sanofi said, under the leadership of Onduo's newly appointed Chief Executive Officer, Joshua Riff, the joint venture will leverage Verily's experience in miniaturized electronics, analytics, and consumer software development, and Sanofi's clinical expertise and experience in bringing innovative treatments to people living with diabetes. Riff joins Onduo from Optum, the health services company of UnitedHealth Group, where he was senior vice president of prevention and wellbeing.